During a normal cell cycle, polyploidy and aneuploidy can be prevented by several checkpoints, which are mainly p53 dependent. Here, we show that treatment of HCT-116 (p53 +/+ ) colon carcinoma cells with the novel antitumor antibiotic mithramycin SK (MSK) results in polyploidization and mitotic catastrophe, which occurs after a transient halt in G 1 phase followed by the overtaking of the G 2 -M checkpoint when treated cells are incubated in a fresh drug-free medium. Cells reentering aberrant mitosis mainly died by necrosis, although active caspase-3 was observed. Our results indicate that a decrease in p53 RNA and protein levels, together with concomitant changes in the expression of other proteins such as p21 WAF1 , were involved in MSK-induced polyploidy. Furthermore, the effects of MSK on HCT-116 (p53 +/+ ) cells cannot be attributed exclusively to the down-regulation of p53 by MSK, because these effects differed from those observed in MSK-treated 
Introduction
The mechanisms by which chemotherapeutic drugs induce tumor cell death are numerous and dependent on various variables, such as the tumor cell type and the mechanism of action of the drug (1) . One model that is frequently cited to explain the mechanisms of chemotherapy indicates that antitumor drugs induce cells to undergo apoptosis and that this induction is often mediated by p53. Thus, alteration of the susceptibility of the cell to undergo apoptosis after treatment is believed to contribute to drug resistance (1, 2) . However, although activation of apoptosis is associated with cell death, its inhibition does not always correlate with cell survival (1, 3) . It has been proposed that programmed senescence might be another mechanism of action of antitumor drugs in some cells (3) . In addition to apoptosis, cells can be effectively killed following DNA damage by other mechanisms, such as mitotic catastrophe (3 -5) . From a morphologic point of view, mitotic catastrophe is the result of aberrant mitosis, which can induce polyploidy (1, 6) and the occurrence of large multinucleated cells and micronucleation (1, 5) . In several cell types, mitotic catastrophe can be accompanied by the activation of caspases, which resembles apoptotic cell death (7 -9) .
Cancer cells often present altered ploidy (10) . In addition to changes in the total number of chromosomes, these cells are aneuploid because they usually contain a variety of other gross chromosomal rearrangements, deletions, and nonreciprocal translocations (10) . Cells entering mitosis after DNA damage may be confronted by the activation of a tetraploidy checkpoint that results in G 1 arrest (10) , which can eventually be followed by apoptosis (11) . However, the presence of this checkpoint in mammalian cells has been challenged (12) . Furthermore, if a hypothetical tetraploidy checkpoint were compromised (e.g., in p53-defective cells), tetraploid cells might proceed through cell division and reenter mitosis, thereby undergoing further polyploidization. This would often result in aneuploidy and cell death, yet viable clones could still emerge (13) .
Treatment with spindle-damaging agents leads to transient mitotic arrest as a result of the activation of the spindle checkpoint, which is followed by mitotic slippage, and the anomalous exit from mitosis without sister chromatid segregation or cytokinesis (13) . However, the resulting tetraploid cells are arrested in G 1 , thereby preventing entry into the S phase and polyploidization (14) . Cells lacking either p53, p21 WAF1 , or pRb are normally arrested in mitosis in response to spindle damage, but after mitotic slippage these cells enter the S phase and endoreplicate their DNA, which results in polyploidization despite their intact spindle checkpoint. This finding indicates strict dependence of the postmitotic G 1 checkpoint on the p53 pathway. The activation of p53 protects healthy cells from polyploidization (10) . Nevertheless, little is known about the molecular mechanisms that cause p53 activation in response to mitotic failure. There is a functional interplay between the mitotic spindle checkpoint and the p53-dependent postmitotic G 1 checkpoint (13) . Cells can activate p53, which leads to G 1 arrest, thereby indicating that tetraploidization itself rather than aberrant exit from mitosis triggers the p53 response (14) .
Regardless of the functional status of p53 protein, death following G 2 arrest has been documented in several cell types in the presence of DNA-damaging agents. Thus, cell death can be accompanied by changes in the expression profile of various genes, including the down-regulation of wild-type p53, which can produce polyploidization as a result of abrogated p53 protein activity (7, 15, 16) . To gain new insights into the effects of p53 down-regulation by DNA-binding drugs, here we used isogenic HCT-116 colon carcinoma cells that differ only in the presence/absence of wild-type p53 alleles (17, 18) .
The aureolic acid antibiotic mithramycin A (MTA), also known as plicamycin, has been used for the treatment of Paget's disease and testicular carcinoma; however, its current clinical use is limited by severe toxicity (2) . The primary cellular target of MTA and related antitumor antibiotics is DNA (19, 20) , whereas bivalent cations, such as Mg 2+ , are an essential requirement for their binding to DNA (19 -21) , which occurs along the minor groove of C/G-rich tracts (19, 20) . MTA inhibits Sp1-DNA interactions both in vivo and in vitro (22) . The inhibition of Sp1 expression by MTA appears to affect the efficacy of antiangiogenic strategies in pancreatic cancer (23) . The biosynthetic pathways of mithramycin have been almost fully elucidated (24 -28) . Mithramycin SK (MSK; Fig. 1A ), a secondary metabolite of MTA, has been generated by insertional inactivation of the gene mtmW in Streptomyces argillaceus (26) . MSK and MTA contain an identical tricyclic chromophore with a unique hydrophilic side chain attached in 3-position and distinct saccharide chains attached in positions 2 and 6. MSK has been tested in vitro against several human cancer cell lines and shows an improved therapeutic index compared with MTA (26) in addition to inhibiting transcription of several genes (29) . The availability of new mithramycin analogues with improved pharmacologic properties, together with a better understanding of their effects on gene expression, opens up new perspectives for the therapeutic use of this class of compounds, which have gained renewed attention as therapeutic agents in cancer-and non-cancer-related diseases (30, 31) .
We observed that HCT-116 (p53 +/+ ) colon carcinoma cells were arrested in G 1 after treatment with MSK. However, after withdrawal of the drug, cells growing in fresh drug-free medium reentered the cell cycle and underwent polyploidization after entering mitosis. Giant cells containing multinuclei and micronuclei were observed before most of the cells were committed to cell death by necrosis, yet caspase-3 activity was observed. In contrast, MSKtreated p53
À/À cells died mainly from G 2 -M through early p53-independent apoptosis, which can be followed by secondary necrosis.
Materials and Methods

Materials
MTA and its secondary metabolite MSK were isolated and purified from the producing organisms as described previously (25, 26) . Stocks of MTA or MSK were prepared as 1 mmol/L solutions in sterile 150 mmol/L NaCl, maintained at -20jC, and brought to the final concentration just before use.
Cell Culture and DrugTreatments HCT-116 (p53 +/+ ) human colon carcinoma cells and its derivative p53 À/À were kindly provided by Dr. B. Vogelstein (Johns Hopkins University). Cells were maintained in 50% Dulbecco's MEM (Life Technologies)/ 50% Ham's F-12 medium (Cambrex), supplemented with 10% fetal bovine serum (Life Technologies), 100 units/mL penicillin, and 100 Ag/mL streptomycin, at 37jC in a humidified atmosphere with 5% CO 2 . Exponentially growing cells subcultured at a density of 2.5 Â 10 4 /mL were incubated with various concentrations of MTA or MSK at 37jC for times indicated in the legend to figures.
Cytotoxicity Assays
The effect of MTA or MSK on HCT-116 cell growth was determined by using the MTT method as described elsewhere (32) . In brief, cells subcultured at a density of 2.5 Â 10 4 /mL were incubated with various concentrations Table S1 ). Experiments labeled ''72 + 24 h'' and ''72 + 72 h'' correspond to continuous treatments for 72 h followed by 24 or 72 h incubation in fresh drug-free medium after withdrawal of the drug.
of MTA or MSK at 37jC for 72 h. After incubation, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (Sigma) was added to each culture.
Cell Cycle Analysis and Flow Cytometry After treatment with either MTA or MSK for various periods, the cells were harvested, fixed with 70% ethanol, and stained with propidium iodide (PI; Sigma) as described elsewhere (32) . Nuclei were analyzed with a Coulter Epics-XL flow cytometer using the 488 nm line of an argon laser and standard optical emission filters.
To analyze the mitotic fraction, fixed cells were incubated with the anti-phospho-histone H3 (Ser 10 ) antibody (Upstate) followed by Cy2-conjugated secondary antibody (Jackson ImmunoResearch). Stained cells were then counterstained with PI and analyzed for Cy2 and PI fluorescence by flow cytometry.
Determination of DNA Synthesis DNA synthesis in MSK-treated cells was assayed by the incorporation of 5 ¶-bromo-2 ¶-deoxyuridine (BrdUrd; Roche Diagnostics) using a fluorescence-conjugated antibody against BrdUrd (BD Biosciences) and costained with PI.
Immunofluorescence Staining HCT-116 cells treated with MSK were fixed with 4% paraformaldehyde, stained with DAPI, and inspected under an Eclipse E-800 fluorescence microscope (Nikon). To observe the mitotic spindle, cells were incubated with anti-h-tubulin antibody (Chemicon International) revealed by anti-mouse Cy3 conjugate (Jackson ImmunoResearch).
The presence of active caspase-3 was determined by using Casp-3a antibody (Cell Signaling Technology) reveled by Cy3-conjugated secondary antibody (Jackson ImmunoResearch) and analyzed under an Eclipse E-800 fluorescence microscope (Nikon).
Assignment of Senescence-Like Growth Arrest and Cell Division
Senescence-like growth arrest was determined, using phase-contrast microscopy, based on the percentage of senescence-associated h-Gal (SA-h-Gal + ) cells (33), using 5-bromo-4-chloro-3-indolyl h-D-galactosidase at pH 6.0.
Assessment of Apoptosis and Necrosis
Necrosis was distinguished from apoptosis by using the Annexin V-Fluos staining kit (Roche Diagnostics) and flow cytometry in a Coulter Epics-XL flow cytometer (Coulter). Necrotic cells were characterized as two populations: Annexin V-Fluos negative/PI positive (primary necrotic cells by lost of membrane ability to exclude PI) and Annexin V-Fluos positive/PI positive (necrosis arising from apoptotic cells or primary necrosis).
The presence of active caspase-3 and caspase-2 was assayed together with changes in mitochondrial membrane potential (DC m ). Cleaved (active) caspase-3 was detected by both fluorescence staining of cells and immunoblotting (described in previous paragraphs), whereas caspase-2 was detected by using the Caspase-2/ICH-1 Colorimetric Protease Assay kit (MBL) as described elsewhere (7). To measure the changes in DC m , untreated and MSK-treated cells were stained with the MitoProbe DilIC (5) Assay kit (Molecular Probes) following the supplier's protocol. Cells were visualized by flow cytometry together with staining with PI to discriminate between living and death MSK-treated cells.
Quantitative Real-time PCR Total RNA was isolated from untreated control cells and cells treated with the IC 75 for MSK using the Ultraspec RNA isolation reagent (Biotecx) following the vendor's guidelines. RNA samples were treated with RNase-free DNase I (Roche Diagnostics) and phenol-extracted.
Quantitative real-time PCR was used to analyze changes in gene expression after 4-h treatments, or 4 h after that the cells were allowed to grow in fresh drug-free medium, following a 72-h continuous treatment with MSK. Total RNA (100 ng, determined spectrophotometrically) was copied to cDNA using the Omniscript RT kit (Qiagen). The appearance of amplified fragments in real time was monitored by the SYBR Green method in an ABI-Prism 7000 Sequence Detection System (Applied Biosystems) using the primers indicated in Supplementary Table S2 . 3 Amplification of the housekeeping glyceraldehyde-3-phosphate dehydrogenase gene was done in parallel to allow normalization among samples. Quantitative real-time PCR conditions included an initial denaturation step at 95jC for 10 min followed by 40 cycles of a denaturation step at 95jC for 15 s and annealing/extension step at 60jC for 1 min. Results are expressed as folds of change in RNA expression of each gene, corrected by the glyceraldehyde-3-phosphate dehydrogenase gene expression.
Western Analysis of Protein Levels Protein was extracted from MSK-treated and control cells, with a lysis buffer consisting of 50 mmol/L Tris-HCl (pH 8), 150 mmol/L NaCl, 5 mmol/L EDTA, 0.5% NP-40, and 0.1 mmol/L phenylmethylsulfonyl fluoride, containing 2 Ag/mL aprotinin and 0.1 Ag/mL leupeptin. Total protein was quantified by the Bradford assay (Bio-Rad). Denatured proteins (f30 Ag) were subjected to electrophoresis on SDS-polyacrylamide gels, blotted onto Optitran BA-S85 membranes (Schleicher & Schuell), probed with the specific antibodies (see Figs. 4 and 5 legends), incubated with secondary antibodies (Jackson ImmunoResearch), and detected by chemiluminescence using Luminol (Sigma).
Clonogenic Assay
To study the final fate of HCT-116 (p53 +/+ ) cells treated with the IC 75 for MSK, cells were stained, after treatment for 72 h, followed by 72 h in drug-free medium, with Hoechst 33422 (Sigma) and analyzed by cytometric sorting of polyploid cells using a MoFlo flow cytometer (DakoCytomation). Optical alignment was based on optimized signal from 10 Am fluorescent beads (Flowcheck; Coulter). Purification of individual polyploid cells using the MoFlo flow cytometer was based in a droplet formation system. Sorting region (>4N) was defined on a Hoescht 33422 integral histogram, and sorting was carried out using a 3 Supplementary material for this article is available at Molecular Cancer Therapeutics Online (http://mct.aacrjournals.org/). Table S1 ). 3 Therefore, we focused our experiments on MSK because it shows cytotoxic effects at lower doses. MTA binds more tightly to DNA than MSK in vitro (21); thus, the greater activity of MSK may be due to its improved cellular uptake (29) or to greater specificity in its cell targeting.
MSK Induces Polyploidization and Mitotic Catastrophe in HCT-116 (p53 +/+ ) Cells HCT-116 (p53 +/+ ) cells treated continuously for 72 h were halted mostly in the G 1 phase of the cell cycle, whereas 48.8% of p53 À/À cells appeared to stop mainly in the S phase (Fig. 1B) Supplementary Fig. S1 ). 3 Senescence induced by MSK in these cells was transient and maintained by the presence of the drug. After the withdrawal of MSK, cells entered mitosis and underwent polyploidization, especially 8N cells, after 24 h in fresh drug-free medium ( Supplementary  Fig. S1C ). 3 Conversely, HCT-116 (p53 À/À ) were not senescent ( Supplementary Fig. S1A ) 3 and accumulated in S phase after withdrawal of MSK (Fig. 1) , although these cells did not synthesize DNA, as described below. The S-like accumulation in p53
À/À cells could be explained by DNA degradation from G 2 -M. After 72 h in fresh drug-free medium all the MSK-treated p53 À/À cells were dead. HCT-116 (p53 +/+ ) cells displayed normal morphology 24 h after withdrawal of MSK (Fig. 2A) . However, after removal of the drug, these cells entered mitosis and showed aberrant mitotic figures after approximately 48 h of growth in fresh drug-free medium and beyond ( Fig. 2A, bottom row) . We observed multipolar attachment of microtubules and a high percentage of large cells containing mitotic figures that showed other abnormalities, including multipolar anaphases and uneven chromosome distribution ( Fig. 2A) .
Furthermore, we did a two-dimensional assay to distinguish between cells that were in G 2 or M (Fig. 2B) . The presence of cells in mitosis during and after treatment with MSK was documented using the mitotic specific marker Ser 10 -phosphorylated histone H3 together with PI staining of DNA. About 4% of control (untreated) HCT-116 (p53 +/+ ) cells were in G 2 -M without polyploidy (Fig. 2B) , whereas treated cells showed polyploidy (>4N cells). There was an increase in both polyploidy and cells entering mitosis from G 2 after withdrawal of MSK. Although polyploidy was detected in fresh drug-free medium, 24 h after withdrawal of the drug (Supplementary Fig. S1C ), 3 the presence of the mitotic marker Ser 10 -phosphorylated histone H3 in cells with >4N content was evident only after 48 h (Fig. 2B, bottom) . Consistent with these results, untreated cells assayed for DNA synthesis by BrdUrd labeling were distributed in G 1 , S, and G 2 -M phases of the cell cycle, whereas cells treated with MSK were also observed as 8N cells, and a S-phase corresponding to DNA synthesis in the polyploid population was observed (Fig. 2C) .
The effect of a continuous 72-h treatment with MSK on HCT-116 (p53 À/À ) was clearly differed because 48.8% of the cells were in S, whereas 30.4% were in G 2 -M rather than in G 1 and committed to die from G 2 -M without apparently entering faulty mitosis. Flow cytometry showed that cells in the S phase corresponded to dead cells with DNA content higher than 2N (Fig. 1B) , thus showing that they were not synthesizing DNA (Fig. 2D) .
MSK Induces Transcriptional Changes in HCT-116 Cells MTA has been described as an inhibitor of the interaction between some transcription factors and gene promoters (22, 34) . Therefore, we sought to gain insights into whether the effects we observed for MSK were also related to a direct effect on the transcription of various key genes involved in checkpoint control and proliferation. Table S2 ). Mean F SD of three experiments. Values were normalized using the expression of the housekeeping glyceraldehyde-3-phosphate dehydrogenase gene. **, P < 0.01; *, P < 0.05, statistically significant changes in transcription of MSK-treated versus untreated cells.
Quantitative RT-PCR experiments revealed the presence of significant changes in the transcription of several genes. Although after a short incubation of HCT-116 cells with MSK (4 h) the transcription of c-myc, cyclin A, and p21 WAF1 was significantly enhanced by the treatment (P < 0.05; Fig. 3A) , this effect was not observed on p53 and Chk1. The transcription of all these genes, except p21 WAF1 , was inhibited significantly (P < 0.01) after 72-h treatments with MSK followed by a 4-h incubation in drug-free medium (Fig. 3B) . In contrast, the transcription of p21 WAF1 was enhanced compared with untreated control cells, an observation that is consistent with the transient halt of cells in G 1 as shown by flow cytometry (Fig. 1B) .
HCT-116 (p53 +/+ ) Cells Treated with MSK Die by Necrosis RatherThan by Apoptosis Figure 4 shows a two-dimensional assay that distinguishes apoptosis from necrosis by using Annexin V-Fluos and PI. HCT-116 (p53 +/+ ) cells treated with MSK for ) colon carcinoma cells were committed to die by necrosis rather than apoptosis even in presence of active caspase 3; whereas p53
À/À cells died by apoptosis mediated by caspase 2. A, flow cytometry of HCT-116 (p53 +/+ ) cells stained with Annexin V-Fluos and PI reveals the absence of Annexin V-Fluos positive/PI negative staining of cells (apoptosis), which does not depend on whether cells were allowed to grow in fresh medium after withdrawal of the drug (top row ) or they were treated continuously with MSK for 96 h (middle row ). The presence of high staining with both Annexin V-Fluos and PI would correspond to leaking necrotic cells and not to primary apoptotic cells that should be not permeable to PI. However, in p53 72 h were allowed to grow in fresh medium after removal of the drug. Cells were dying by necrosis (high staining with PI), whereas there was no presence of apoptotic cells (Annexin V-Fluos positive). A direct morphologic analysis, made in parallel, using double fluorescence staining consisting of DAPI and a specific antibody for active caspase-3, showed that the large cells contained multipolar mitotic figures (Fig. 4B) and some of these cells were multinucleated, in keeping with the rise of mitotic catastrophe. These mitotic figures were also observed in cells showing caspase-3 staining, yet the cytometry results indicated that these cells did not undergo apoptosis (absence of Annexin V-Fluos staining; Fig. 4) . The presence of active forms of caspase-3 in p53 +/+ cells dying by ''primary'' necrosis (Annexin V-Fluos negative/PI positive) was also confirmed by Western blot (Fig. 4C) .
Direct analysis of changes in DC m indicated that treatment of HCT-116 (p53 +/+ ) cells with MSK did not produce a significant disruption of the membrane potential (Fig. 4D) , whereas a significant (P < 0.05), yet moderate, decrease in this potential was observed in MSK-treated p53 À/À cells (Fig. 4D) . In HCT-116 (p53 À/À ) cells, MSK induced a primary apoptotic pathway from G 2 -M, which was mediated by caspase-2 ( Supplementary Fig. S2 ).
3 Some apoptotic p53
À/À cells eventually showed a secondary (Annexin V-Fluos positive/PI positive) necrotic phenotype ( Fig. 2A) , Moreover, the p53 À/À cells died from G 2 -M arrest, apparently without entering mitosis, as the mitotic marker Ser 10 -phosphorylated histone H3 was not observed (not shown).
Changes in Protein Levels Might Explain the Fate of HCT-116 Cells afterTreatment with MSK
Protein levels in p53 +/+ cells were analyzed by Western blot to check whether changes in RNA levels (Fig. 3) were followed by a decrease in the corresponding protein.
Moreover, we also examined protein levels in p53 À/À cells to check for changes that may explain their peculiar behavior after treatment with equitoxic concentrations of MSK. Figure 5 shows time-dependent changes in p21
WAF1
, p53, and cyclin B, whereas those corresponding to the active form of caspase-3 were described above because of their direct relevance in cell death mechanisms (Fig. 4C) . A quantification of the changes in protein levels is shown as in Supplementary Fig. S3 . 3 In p53 +/+ cells, p53 levels increased during MSK treatment up to 72 h, but decreased after removal of the drug (Fig. 5A) , which may facilitate polyploidy (13) . After withdrawal of the drug, the presence of p21 WAF1 was also slightly reduced (Fig. 5A) , which was by the time cells were arrested in G 1 , and after a 72-h incubation in drug-free medium, this protein was undetectable. Meanwhile, cyclin B levels increased after removal of the drug, which is consistent with the entry of HCT-116 (p53 +/+ ) into mitosis. In p53 +/+ cells, a 72-h treatment with 25 nmol/L MSK (its IC 75 ) reduced the levels of c-myc (Fig. 5B) . However, after withdrawal of the drug, cells growing in fresh drug-free medium synthesized the protein to the same extent as untreated controls (Fig. 5B) . Interestingly, the time-dependent changes induced by MSK in c-myc and p21 WAF1 levels were in opposite directions: one increased, whereas the other decreased (cf. Fig. 5A and B), in concordance with that c-myc would negatively regulate p21 WAF1 . In HCT-116 (p53 À/À ) cells, p21 WAF1 decreased after withdrawal of the drug (''72 + 24 h'' track in Fig. 5C ) and there was also a small change in cyclin B protein levels, in line with a transient halt in G 2 -M after 72 h of continuous treatment with MSK, before cells entered apoptosis (see above). The p53 protein was not detected (Fig. 5C) , as expected in this p53-mutant cell line (17) .
A Clonogenic Analysis of Polyploid Cells Induced by MSK RevealsThat Several Multinucleated Cells Survive in the Absence of Cytokinesis Sorted (individual) HCT-116 (p53 +/+ ) polyploid cells obtained after a 72-h continuous treatment with MSK, followed by 72 h in drug-free medium, were analyzed for clonogenic capacity, after being seeded as individual polyploid cells, for up to 14 days in fresh medium. Of these clones, 75.6% were committed to die in the following days (Fig. 6A) . However, the surviving cells showed an increase in size and were multinucleated (Fig. 6B) , Table S1 ).
The proteins displayed are involved in cell cycle control and proliferation. suggesting that they were entering mitosis (endoreplication) without cytokinesis. MSK was lethal for most of the cells, whereas a small number, with seemingly increased aneuploidy, survived.
Discussion
We have shown that MSK produced polyploidy in HCT-116 (p53 +/+ ) colon carcinoma cells as these cells were only transiently halted at the cell cycle checkpoints. During a normal cell cycle, polyploidization can be prevented by a p53-dependent G 1 checkpoint, the G 2 checkpoint, and the mitotic spindle checkpoint (10) . Moreover, polyploidy can be avoided by preventing these cells from reentering mitosis by an additional ''tetraploidy checkpoint'' (11, 35) . This ''tetraploidy checkpoint'' would require, together with an intact spindle checkpoint, the presence of active p53, which is fundamental for postmitotic G 1 arrest and the prevention of polyploidy upon aberrant exit from mitosis (11, 13) . After the withdrawal of MSK, a decrease in p53 levels was observed in HCT-116 (p53 +/+ ) cells. These results are consistent with previous observations that both p53 accumulation and a prolonged mitotic arrest are required for efficient postmitotic G 1 arrest (13) . MSK appeared to ''facilitate'' the reentry of cells into mitosis, thus causing mitotic catastrophe. However, HCT-116 (p53 À/À ) cells, which are defective in checkpoint controls (17) , died from G 2 -M after treatment with MSK by p53-independent apoptosis (36) . This finding is in keeping with the observation that p53 deletion in HCT-116 cells leads to greater apoptosis induced by some, but not all, antitumor drugs (18) .
Regardless of the presence of active caspase-3, HCT-116 (p53 +/+ ) cells treated with MSK were chiefly committed to cell death by necrosis rather than apoptosis. Here, we show massive necrosis in cells bearing wild-type p53 and active caspase-3. It has been suggested that, when mitotic catastrophe occurs after DNA damage, cells are most likely to undergo slippage and multinucleation followed by nonapoptotic cell death (35) , because apoptosis-prone cells, bearing damaged DNA, die before entering mitosis. Both caspase-dependent and caspase-independent mechanisms of cell death after mitotic catastrophe have been reported (7, 8, 37 -39) , which may end in either necrosis or apoptosis (3, 5) . The mode of cell death would be determined by the cell context. The down-regulation of p53 by MSK and the large cell size, which were the result of damaged cells reentering mitosis together with the absence of cytokinesis, might produce cells that die during the abrupt onset of a general malfunction, including permeabilization of cell membranes. This notion was substantiated by the high uptake of PI in the presence of only 3% staining with Annexin V-Fluos. Our results suggest that the rate of necrosis is higher than that of apoptosis, which induces MSK-treated HCT-116 (p53 +/+ ) cells to undergo necrosis even in the presence of active caspase-3, whereas in p53 À/À cells apoptosis was mediated by caspase-2. When treated with MSK, HCT-116 (p53 +/+ ) cells did not exhibit significant DC m dissipation (Fig. 4D) , which is in line with the absence of apoptosis in these cells. In contrast, the homologous p53 À/À cells showed a slight, although significant, decrease in mitochondrial potential, in accordance with a previous observation that tetraploid cells treated with the DNA-damaging agent cisplatin manifest less pronounced DC m dissipation (11) .
When p53 is activated in response to some cell cycle errors (1, 10) , proapoptotic pathways can also be activated. In contrast, we have shown that the inhibition of p53 expression by MSK results in the generation of a polyploid state, whereas the enhancement of p21 WAF1 expression contributes to this state (Fig. 3) . This observation agrees with the finding that p21
WAF1 is not only a mediator of p53 tumor suppression (40) but also a negative regulator of p53 stability (41) .
Although it has been proposed that tetraploidization ends in apoptosis as a safeguard mechanism of cells (11), we conclude that necrosis could replace this process. This finding is not at variance with tetraploidy causing a shift toward resistance to apoptosis (11) . It is worth noting that HCT-116 (p53 À/À ) cells are not necessarily polyploid ( Fig. 1B; ref. 17) . Therefore, additional genes are involved in preventing polyploidy (42) . Although p53 is usually activated after DNA damage and it is essential to control cell death (17, 43) , our results suggest that direct inhibition of p53 or its target genes by MSK is involved in the mechanism by which cells reenter mitosis.
The inhibition of Sp1 binding to the promoters of several p53 target genes, such as the p21 WAF1 gene and certain proapoptotic genes, by MTA abrogates the transcriptional induction of these genes by p53, a mechanism that could account for some of the tumor-suppressing and antiapoptotic effects of this drug (34) . Based on our results, we propose that this inhibition also occurs with the structurally related MSK, which shows improved therapeutic characteristics (26) . We observed the inhibition of p53 transcription (Fig. 3) and the concomitant reduction of p53 protein levels, together with an increase in cyclin B, in addition to other changes, after treatment of cells with MSK (Fig. 5) . These findings indicate that p53 did not cause efficient transcriptional activation of some key genes in MSK-treated p53 +/+ cells, and thereby an increase in ''the rate of spontaneous apoptosis'' (9) did not occur, which we have made evident when MSK-treated cells were incubated in drug-free medium.
The MSK-induced inhibition of p53 transcription in HCT-116 (p53 +/+ ) cells was accompanied by unremitting levels of activated p21 WAF1 when cells were allowed to grow in drug-free medium, with a corresponding reduction in the proteins levels, which were not sufficient to prevent the overtaking of the G 1 and G 2 -M checkpoints, with some cells reentering faulty mitosis. These observations are consistent with previous reports that neither p21 WAF1 nor 14-3-3j are sufficient to prevent mitotic catastrophe (14) . Our results are also in line with the report that exposure of transformed cells to DNA-binding drugs results in an induction of p21 WAF1 levels and increased ploidy (44) . What is peculiar about the effects of MSK is that p53 protein levels were sufficiently reduced to drive cells to act as if they were deficient in wild-type p53, although our results indicate that their behavior is not equivalent to the effects of MSK observed in HCT-116 (p53 À/À ) cells. MSK induced p53
À/À cells to stop only transiently at the distinct checkpoints and to undergo apoptosis from G 2 -M. The main reason for this situation, compared with p53 +/+ cells, might be the known control of the G 1 checkpoint by p53. The differences in the effects of MSK on p53 +/+ and p53 À/À cells are consistent with the report that p53 is not required for apoptosis induced by DNA damage (45) and also with that the effects of MSK on transcription (Fig. 3) have to be more complex that the direct reduction in p53 levels.
Although most of the HCT-116 (p53 +/+ ) cells eventually died in a time-dependent way, as shown by a clonogenic assay, some were still alive after 14 days in fresh drug-free medium, which, added to the previous 72 h in the presence of the IC 75 for MSK plus incubation for 72 h in drug-free medium, represents a lifespan of at least 20 days. The assay results shown in Fig. 6 cannot be considered sensu stricto a clonogenic assay because cells were not dividing (forming a clone) but undergoing several rounds of endoreplication and mitosis in the absence of cytokinesis, with polyploidy frequently preceding aneuploidy (13) . It is worth noting that surviving cells might undergo an induced, yet timedependent, enhancement of p21 WAF1 protein levels, which has been identified as a major cause of genetic instability and tumor progression (44) .
Connections between the mitotic spindle assembly, p53 status, arrest of the cell cycle at checkpoints, and aneuploidy have been described (11, 13, 46, 47) . However, there are several reports indicating that changes in the transcriptome induced by DNA-binding drugs facilitate the overtaking of these and other checkpoints and thus contribute to an increase in polyploidy and mitotic catastrophe (7, 16, 18, 37, 48, 49 cells, which sometimes underwent secondary necrosis) regardless of the presence of active caspase-3 in the former. Therefore, it follows that the link between mitotic catastrophe and the apoptotic machinery remains partially elusive and requires further characterization. The distinct responses of HCT-116 cells to MSK-induced cytotoxicity suggest that the appearance of apoptosis after DNA damage depends not only on the concentration of the drug, as it has been suggested previously (45, 48) , but also on the genetic background of the cell beyond the p53 status.
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